ACRO Biomedical Co., Ltd. (TPEX:6748)

Taiwan · Delayed Price · Currency is TWD

176.00

-8.00 (-4.35%)

Sep 8, 2026, 12:17 PM CST

ACRO Biomedical Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	52.76	38.26	44.23	51.06	27.63	21.83
Revenue Growth	37.91%	-13.51%	-13.38%	84.79%	26.59%	21.04%
Gross Profit	33.85	18.53	26.19	39.12	13.43	14.54
Operating Income	-94.07	-92.22	-64.65	-48.67	-62.78	-53.56
Net Income	-78.79	-82.66	-62.09	-41.42	-60.88	-50.78
Earnings Per Share	-1.19	-1.35	-1.01	-0.79	-1.29	-1.43
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other	0.17	0.14	1.92	1.63	0.19	-
AGO Biomedical	52.59	38.12	42.32	49.44	27.45	21.83
Total	52.76	38.26	44.23	51.06	27.63	21.83

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	916.68	977.87	498.95	579.23	316.85	62.97
Total Debt	33.63	10.59	15.85	21.1	10.92	13.32
Net Cash (Debt)	883.05	967.28	483.1	558.13	305.93	49.65
Net Cash Growth	-8.71%	100.22%	-13.44%	82.43%	516.20%	-51.44%
Net Cash Per Share	13.33	15.79	7.89	10.59	6.46	1.40

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-72.33	-49.01	-43.38	-48.27	-45.15	-47.83
Capital Expenditures	-9.22	-12.82	-30.55	-21	-2.74	-0.37
Free Cash Flow	-81.55	-61.83	-73.93	-69.27	-47.89	-48.2
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.17%	48.43%	59.21%	76.60%	48.59%	66.62%
Operating Margin	-178.30%	-241.06%	-146.17%	-95.31%	-227.17%	-245.35%
Pretax Margin	-149.34%	-216.06%	-140.33%	-81.11%	-220.33%	-232.61%
Profit Margin	-149.34%	-216.06%	-140.37%	-81.11%	-220.33%	-232.61%
FCF Margin	-154.57%	-161.62%	-167.13%	-135.66%	-173.30%	-220.80%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	213.51	105.62	35.36	47.18	37.07	43.02